These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25558076)

  • 1. Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species.
    Lamoth F; Alexander BD; Juvvadi PR; Steinbach WJ
    J Antimicrob Chemother; 2015 May; 70(5):1408-11. PubMed ID: 25558076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.
    Lamoth F; Juvvadi PR; Gehrke C; Steinbach WJ
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1035-9. PubMed ID: 23165466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
    Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
    Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
    Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.
    Juvvadi PR; Lee SC; Heitman J; Steinbach WJ
    Virulence; 2017 Feb; 8(2):186-197. PubMed ID: 27325145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    Garcia-Effron G; Gomez-Lopez A; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.
    Lamoth F; Alexander BD
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4308-11. PubMed ID: 25896696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the Hsp90-Calcineurin Pathway in the Antifungal Activity of Honokiol.
    Liao K; Sun L
    J Microbiol Biotechnol; 2018 Jul; 28(7):1086-1093. PubMed ID: 29913547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi.
    Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S
    J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Garcia-Effron G; Monzon A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5136-8. PubMed ID: 16304186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE; Wiederhold NP; Klepser ME
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70 and the Cochaperone StiA (Hop) Orchestrate Hsp90-Mediated Caspofungin Tolerance in Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Soderblom EJ; Moseley MA; Steinbach WJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4727-33. PubMed ID: 26014950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.
    Blatzer M; Blum G; Jukic E; Posch W; Gruber P; Nagl M; Binder U; Maurer E; Sarg B; Lindner H; Lass-Flörl C; Wilflingseder D
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3778-88. PubMed ID: 25870060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.